CELCUITY INC's ticker is CELC and the CUSIP is 15102K100. A total of 58 filers reported holding CELCUITY INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,582 | -12.6% | 8,707 | +5.0% | 0.00% | 0.0% |
| Q2 2023 | $91,068 | +102.4% | 8,294 | +72.8% | 0.00% | – |
| Q1 2022 | $45,000 | -33.8% | 4,800 | -6.6% | 0.00% | – |
| Q4 2021 | $68,000 | -28.4% | 5,137 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $95,000 | -11.2% | 5,292 | +18.5% | 0.00% | – |
| Q2 2021 | $107,000 | +365.2% | 4,467 | +28.3% | 0.00% | – |
| Q1 2020 | $23,000 | -41.0% | 3,483 | -5.5% | 0.00% | – |
| Q4 2019 | $39,000 | -38.1% | 3,684 | -0.8% | 0.00% | – |
| Q3 2019 | $63,000 | -33.0% | 3,715 | -0.7% | 0.00% | – |
| Q2 2019 | $94,000 | +16.0% | 3,741 | +0.9% | 0.00% | – |
| Q1 2019 | $81,000 | -12.0% | 3,706 | -3.2% | 0.00% | – |
| Q4 2018 | $92,000 | -17.1% | 3,827 | -0.7% | 0.00% | – |
| Q3 2018 | $111,000 | +18.1% | 3,855 | +1.8% | 0.00% | – |
| Q2 2018 | $94,000 | +224.1% | 3,786 | +112.3% | 0.00% | – |
| Q1 2018 | $29,000 | -19.4% | 1,783 | -5.1% | 0.00% | – |
| Q4 2017 | $36,000 | – | 1,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,105,386 | $23,117,138 | 3.70% |
| Soleus Capital Management, L.P. | 1,923,283 | $21,117,647 | 2.35% |
| COMMODORE CAPITAL LP | 1,444,141 | $15,856,668 | 1.78% |
| NEA Management Company, LLC | 1,250,001 | $12,725,011 | 0.97% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 66,209 | $726,975 | 0.82% |
| RA Capital Management | 1,400,001 | $15,372,011 | 0.29% |
| GAGNON SECURITIES LLC | 53,719 | $589,834 | 0.12% |
| PFM Health Sciences, LP | 257,713 | $2,829,689 | 0.11% |
| J. Goldman & Co LP | 135,000 | $1,482,300 | 0.05% |
| Murphy Pohlad Asset Management LLC | 11,200 | $122,976 | 0.05% |